Daisuke Nitta

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Magnetic Resonance

Body Mass Index

Top Venues

Expert opinion on drug safety

ESC heart failure

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroyuki Tsutsui, Hiroyuki Sakamaki, Shin-Ichi Momomura, Yasushi Sakata, Yutaro Kotobuki, Stephan Linden, Koki Idehara, Daisuke Nitta
Empagliflozin cost-effectiveness analysis in Japanese heart failure with mildly reduced and preserved ejection fraction. ESC heart failure (2023)
Kohei Kaku, Kazuhiro Yamamoto, Yumiko Fukushima, Seiko Mizuno, Daisuke Nitta
Safety and effectiveness of empagliflozin according to body mass index in Japanese patients with type 2 diabetes: a subgroup analysis of a 3-year post-marketing surveillance study. Expert opinion on drug safety (2022)
Nobuya Inagaki, Takaaki Nishimoto, Yoichi Nishiya, Daisuke Nitta
Safety and effectiveness of empagliflozin and linagliptin fixed-dose combination therapy in Japanese patients with type 2 diabetes: final results of a one-year post-marketing surveillance study. Expert opinion on drug safety (2022)